Drugs & Therapy Perspectives

, Volume 10, Issue 8, pp 13–16 | Cite as

Upper RTIs: common childhood bacterial infections with major cost implications

Drug Economics and Quality of Life


Otitis Medium Pertussis Azithromycin Acute Otitis Medium Rheumatic Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hoppe JE. Rational prescribing of antibacterials in ambulatory children. Pharmacoeconomics 1996; 10(6): 552–74PubMedCrossRefGoogle Scholar
  2. 2.
    Bass JW. Antibiotic management of group A streptococcal pharyngotonsillitis. Pediatr Infect Dis J 1992; 11: 1043–6CrossRefGoogle Scholar
  3. 3.
    Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics 1995; 96: 758–64PubMedGoogle Scholar
  4. 4.
    Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis 1992; 14 Suppl. 2: 218–23CrossRefGoogle Scholar
  5. 5.
    Stewart A, Phillips R. Antibiotic treatment for paediatric streptococcal pharyngitis: estimation of costs in general practice. Br J Med Econ 1994; 7: 123–6Google Scholar
  6. 6.
    Cherry JD, Brunell PA, Golden GS, et al. Report of the task force on pertussis and pertussis immunisation — 1988. Pediatrics 1988; 81: 939–84Google Scholar
  7. 7.
    Lewis K, Saubolle MA, Tenover FC, et al. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 1995; 14:388–91PubMedCrossRefGoogle Scholar
  8. 8.
    Hoppe JE, Halm U, Haedorn HJ, et al. Comparison of erythromycin ethylsuccinate and cotrimoxazole for treatment of pertussis. Infection 1989; 17: 227–31PubMedCrossRefGoogle Scholar
  9. 9.
    Cotrimoxazole: rationale for re-examining its use for common infections. Drug Ther Perspect 1997 Jan 20; 9(1): 12–14Google Scholar
  10. 10.
    British National Formulary No 33. London: The Pharmaceutical Press, 1997 Mar: 253Google Scholar
  11. 11.
    Froom J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997; 315: 98–101PubMedCrossRefGoogle Scholar
  12. 12.
    Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with otitis media? A meta-analysis. BMJ 1997; 314: 1526–9PubMedCrossRefGoogle Scholar
  13. 13.
    van Buchem FL, Peeters MF, van’t Hof MA. Acute otitis media: a new treatment strategy. BMJ (Clin Res Ed) 1985 Apr 6; 290: 1033–7CrossRefGoogle Scholar
  14. 14.
    Paradise JL. Managing otitis media: a time for change. Pediatrics 1995; 96: 712–5PubMedGoogle Scholar
  15. 15.
    Pichichero ME. Assessing the treatment alternatives for acute otitis media. Pediatr Infect Dis J 1994; 13: S27–34PubMedCrossRefGoogle Scholar
  16. 16.
    Cohen R. The antibiotic treatment of acute otitis media and sinusitis in children. Diagn Microbiol Infect Dis 1997; 27: 35–9PubMedCrossRefGoogle Scholar
  17. 17.
    van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, Peeters MF. Lancet 1997; 349: 683–7PubMedCrossRefGoogle Scholar
  18. 18.
    Wald ER. Sinusitis in children. N Engl J Med 1992; 326: 319–23PubMedCrossRefGoogle Scholar
  19. 19.
    Wald ER. Acute sinusitis in children. Adv Otolaryngol Head Neck Surgery 1988; 2: 165–88Google Scholar
  20. 20.
    Giebink GS. Childhood sinusitis: pathophysiology, diagnosis and treatment. Pediatr Infect Dis J 1994; 13: S55–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1997

Personalised recommendations